Patents by Inventor William A. Watson

William A. Watson has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20060167248
    Abstract: The present invention relates to morpholine and thiomorpholine derivatives of the general formula I or pharmaceutically acceptable salts thereof and their use.
    Type: Application
    Filed: December 21, 2005
    Publication date: July 27, 2006
    Inventors: Christian Tornoe, Mario Rottlander, Nikolay Khanzhin, Andreas Ritzen, William Watson
  • Publication number: 20060155121
    Abstract: The present invention relates to aniline derivatives of the general formula I or salts thereof and their use.
    Type: Application
    Filed: December 20, 2005
    Publication date: July 13, 2006
    Inventors: Christian Tornoe, Mario Rottlander, Daniel Greve, Nikolay Khanzhin, Andreas Ritzen, William Watson
  • Patent number: 7062219
    Abstract: The present invention provides protein single-color and multi-color protein fragment complementation assays for drug discovery, in particular to identify compounds that activate or inhibit cellular pathways. Based on the selection of an interacting protein pair combined with an appropriate PCA reporter such as monomeric enzymes and fluorescent proteins, the assays may be run in high-throughput or high-content mode and may be used in automated screening of libraries of compounds. Methods are described for constructing such assays for one or more steps in a biochemical pathway; testing the effects of compounds from combinatorial, natural product, peptide, antibody, nucleic acid or other diverse libraries on the protein or pathway(s) of interest; and using the results of the screening to identify specific compounds that activate or inhibit the protein or pathway(s) of interest. The development of such assays provides for a broad, flexible and biologically relevant platform for drug discovery.
    Type: Grant
    Filed: February 5, 2004
    Date of Patent: June 13, 2006
    Assignee: Odyssey Thera Inc.
    Inventors: Stephen William Watson Michnick, Ingrid Remy, Marnie MacDonald, Jane Lamerdin, Helen Yu, John K. Westwick
  • Patent number: 7035849
    Abstract: A rules analyzer system and method is provided for an enterprise system to evaluate and rank exact and probabilistic search rules for searching a computer database of records according to the efficiency of each search rule. The rules analyzer collects statistics on the performance of each search rule and assigns a priority value for each search rule according to the collected statistics. The priority values are based on the efficiency or precision of each search rule. Thereafter, the rules analyzer ranks the search rules according to the assigned priority.
    Type: Grant
    Filed: January 21, 2003
    Date of Patent: April 25, 2006
    Assignee: Eclipsys Corporation
    Inventor: William Watson Tifft
  • Publication number: 20060054407
    Abstract: A transmission lubrication system for a vehicle transmission includes a fluid collection chamber positioned to collect fluid thrown by a rotatable member within the transmission. Structure forming a flow passage extending from the fluid collection chamber is in fluid communication with a transmission component so that the collected fluid flows from the fluid collection chamber via the flow passage to the transmission component to lubricate the transmission component.
    Type: Application
    Filed: May 18, 2005
    Publication date: March 16, 2006
    Inventors: Kirk Wirth, William Watson, Edward Greenan
  • Patent number: 6929916
    Abstract: The present invention describes a method for detecting biomolecular interactions said method comprising: (a) selecting an appropriate reporter molecule selected from the group consisting of a protein, a fluorescent protein, a luminescent protein and a phosphorescent protein; (b) effecting fragmentation of said reporter molecule such that said fragmentation results in reversible loss of reporter function; (c) fusing or attaching fragments of said reporter molecule separately to other molecules; followed by (d) reassociation of said reporter fragments through interactions of the molecules that are fused to said fragments; and (e) detecting said biomolecular interactions by reconstitution of activity of the reporter molecule with the proviso that said protein is not ubiquitin.
    Type: Grant
    Filed: May 24, 2002
    Date of Patent: August 16, 2005
    Assignee: Odyssey Thera Inc.
    Inventors: Stephen William Watson Michnick, Joelle Nina Pelletier, Ingrid Remy
  • Patent number: 6919059
    Abstract: Oxygen or oxygen-enriched air is employed to support combustion in furnaces (16) and (26) of part of the hydrogen sulphide content of a first feed gas stream. Sulphur vapour is extracted in condenser (32) from the resulting gas mixture so as to form a sulphur vapour depleted gas stream. The sulphur vapour depleted gas stream is passed into a catalytic reduction reactor (40) in which all the residual sulphur dioxide is reduced to hydrogen sulphide. This reduced gas mixture has water vapour extracted therefrom in a quench tower (52). The resulting water vapour depleted gas stream flows to a Claus plant for treatment typically together with a second feed gas steam comprising hydrogen sulphide. Employing both furnaces (16) and (26) makes it possible to obtain effective conversions to sulphur of the hydrogen sulphide in the feed gas without having the recycle any of the water vapour depleted gas.
    Type: Grant
    Filed: September 4, 2001
    Date of Patent: July 19, 2005
    Assignee: The BOC Group plc
    Inventors: Richard William Watson, Stephen Rhys Graville
  • Patent number: 6897017
    Abstract: The present invention describes a rapid and efficient in vivo library-versus-library screening strategy for identifying optimally interacting pairs of heterodimerizing polypeptides. It allows for the screening of a protein library against a second protein library, rather than against a single bait protein, and thus has numerous applications in the study of protein-protein interactions. Additionally, it allows for the application of different selection stringencies. Two leucine zipper libraries, semi-randomized at the positions adjacent to the hydrophobic core, were genetically fused to either one of two designed fragments of the enzyme murine dihydrofolate reductase (mDHFR), and cotransformed into E. coli. Interaction between the library polypeptides was required for reconstitution of the enzymatic activity of mDHFR, allowing bacterial growth.
    Type: Grant
    Filed: June 26, 2000
    Date of Patent: May 24, 2005
    Assignee: Odyssey Thera Inc.
    Inventors: Stephen William Watson Michnick, Joelle N. Pelletier, Katja M. Arndt, Andreas Pluckthun
  • Patent number: 6893620
    Abstract: Oxygen or oxygen-enriched air is employed to support combustion in furnace (16) of part of the hydrogen sulphide content of a first feed gas stream. Sulphur is extracted from the resulting gas stream in a sulphur condenser (26). Catalyst Claus reaction between hydrogen sulphide and sulphur dioxide in the resulting sulphur vapour depleted gas stream takes place in a catalytic reactor (32). Sulphur is extracted in a further sulphur condenser (34). The resulting sulphur vapour depleted gas stream is passed into a catalytic reduction reactor (40) in which all the residual sulphur dioxide and any sulphur vapour are reduced to hydrogen sulphide. The resulting reduced gas mixture has water vapour extracted there from in a quench tower (52). The resulting water vapour depleted gas stream flows to a Claus plant for further treatment typically together with a second feed gas stream.
    Type: Grant
    Filed: September 4, 2001
    Date of Patent: May 17, 2005
    Assignee: The BOC Group plc
    Inventors: Richard William Watson, Stephen Rhys Graville
  • Publication number: 20050093540
    Abstract: A first magnetic field generated by a first coil operatively associated with a first portion of a vehicle interacts with at least one conductive element operatively associated with or at least a part of a second portion of the vehicle so as to generate an eddy current in the conductive element, which affects the magnetic field sensed by a magnetic sensor. A conductive element operatively coupled to a portion of the vehicle susceptible to a crash, e.g. a bumper or a door, provides for sensing a crash with the signal from the magnetic sensor. In another aspect, a second magnetic field is generated in the frame of a vehicle by a second coil wherein the frame is adapted so that the reluctance of the associated magnetic circuit is responsive to a crash. Signals from the first or second coils may be used to sense the associated magnetic fields.
    Type: Application
    Filed: September 20, 2004
    Publication date: May 5, 2005
    Inventors: William Merrick, William Watson, Timothy Bomya, Leonard Cech
  • Publication number: 20050096881
    Abstract: A signal generated responsive to a magnetic field in a magnetic circuit is decomposed into first and second filtered signals, wherein, at at least one first frequency, a magnitude of a component of the first filtered signal is greater than that of the second filtered signal, and at at least one second frequency greater than the at least one first frequency, a magnitude of a component of the second filtered signal is greater than that of the first filtered signal. A condition of a magnetic circuit is sensed responsive to the first and second filtered signals. In one embodiment, actuation of a safety restraint actuator of a vehicle is controlled responsive to the sensed condition of the magnetic circuit that includes a portion of the vehicle susceptible to a crash. A deployment threshold is adjusted responsive to a door opening state.
    Type: Application
    Filed: September 20, 2004
    Publication date: May 5, 2005
    Inventors: William Watson, Leonard Cech, Debra Rice
  • Patent number: 6872871
    Abstract: Protein Fragment Complementation Assays (PCA) are done in plant material using enzyme fragment constructs, for example, dihydrofolate reductase (DHFR) fragment constructs. Plant material is transformed with at least two different constructs that form different products capable of interacting to reconstitute enzymatic activity in the plant material. Detection of the activity can be done using a substrate for the enzyme in the culture medium which, when reacted with the enzyme, is converted to a detectable product. One embodiment uses a substrate that can be enzymatically converted to a detectable fluorescent product. An inducer such as rapamycin or salicylic acid can be added to the culture medium to increase the level of detectable product.
    Type: Grant
    Filed: May 9, 2001
    Date of Patent: March 29, 2005
    Assignee: Odyssey Thera Inc.
    Inventors: Normand Brisson, Stephen William Watson Michnick
  • Patent number: 6860697
    Abstract: A tray unloader for rod-like articles of the tobacco industry includes a horizontally-movable, slidable carriage supporting an independently-driven tray inverting carrier arranged to pick up an upright full tray from a receiving position and invert it during movement to an unloading position. In the unloading position articles are received directly over opposed horizontal bands having a delivery channel between confronting ends and defining the initial level at which articles are received over most of the width of the tray. Downstream of the channel is a conveyor which operates at a relatively high rate during a first phase of unloading for each tray and at a reduced rate during a second phase, so as to allow controlled emptying of the tray and establishment of the residual level of articles in the channel after completion of unloading of each tray.
    Type: Grant
    Filed: April 5, 2001
    Date of Patent: March 1, 2005
    Assignee: Molins Plc
    Inventors: Robert Mann Bradbury, William Albert Cupp, Michael Kent, Paul Malcolm Meade, Dirk Pruessmann, William Joseph Schreier, Jr., Philip Neil Theurer, Clive William Watson
  • Patent number: 6829604
    Abstract: A rules analyzer system and method is provided for an enterprise system to evaluate and rank exact and probabilistic search rules for searching a computer database of records according to the efficiency of each search rule. The rules analyzer collects statistics on the performance of each search rule and assigns a priority value for each search rule according to the collected statistics. The priority values are based on the efficiency or precision of each search rule. Thereafter, the rules analyzer ranks the search rules according to the assigned priority.
    Type: Grant
    Filed: October 19, 2000
    Date of Patent: December 7, 2004
    Assignee: Eclipsys Corporation
    Inventor: William Watson Tifft
  • Patent number: 6828099
    Abstract: The present invention describes an assay method comprising: (A) generating (1) at least a first fragment of a reporter molecule linked to a first interacting domain and at least a second fragment of a reporter molecule linked to a second interacting domain, or (2) nucleic acid molecules that code for (A)(1) and subsequently allowing said nucleic acid molecules to produce their coded products; then, (B) allowing interaction of said domains; and (C) detecting reconstituted reporter molecule activity, where said reporter molecule can react with a penicillin- or a cephalosporin-class substrate.
    Type: Grant
    Filed: May 31, 2001
    Date of Patent: December 7, 2004
    Assignee: Odyssey Thera Inc.
    Inventors: Stephen William Watson Michnick, André Galarneau
  • Publication number: 20040241636
    Abstract: The cell-based assays described in the present invention can be used to directly assess the sensitivity and specificity of the gene annotation reagent against its target, and to determine if a non-targeted gene participates in a pathway of interest or is functionally linked to another gene or protein. The combination of annotation reagents with such cell-based assays is useful for mapping genes (proteins) into cellular pathways on a genome-wide scale. Preferred assay embodiments include fluorescence or luminescence assays in intact (live or fixed) cells. Such fluorescence or luminescence assays include high-throughput or high-content assays for protein activity, subcellular localization, post-translational modifications, or interactions of proteins. Suitable assays may include protein-protein interaction assays; protein translocation assays; and post-translational modification assays.
    Type: Application
    Filed: May 29, 2004
    Publication date: December 2, 2004
    Inventors: Stephen William Watson Michnick, Barbara Belisle, Marnie L. MacDonald, John K. Westwick, Jane Elizabeth Lamerdin
  • Publication number: 20040229240
    Abstract: The present invention describes rapid and efficient methods to screen for biomolecular interactions in vivo based on protein fragment complementation assays (PCA). Examples are given that demonstrate the utility of the invention and the specific advantages of PCA that are not met by other library screening methods. In a first example, we demonstrate an in vivo library-versus-library screening strategy that has numerous applications in the identification of novel protein-protein interactions and in directed evolution. In another example we demonstrate the detection of protein-protein interactions starting with defined (full-length) cDNAs, and the concomitant generation of functional assays that provide initial validation of the cDNA products as being biologically relevant. In yet another example we demonstrate cDNA library screening in mammalian cells using a bait-vs.-library strategy combined with fluorescence detection.
    Type: Application
    Filed: December 5, 2003
    Publication date: November 18, 2004
    Inventors: Stephen William Watson Michnick, Ingrid Remy, Jane Lamerdin
  • Publication number: 20040161787
    Abstract: The present invention provides protein fragment complementation assays for drug discovery, in particular to identify compounds that activate or inhibit cellular pathways. Based on the selection of an interacting protein pair combined with an appropriate PCA reporter, the assays may be run in high-throughput or high-content mode and may be used in automated screening of libraries of compounds. The interacting pair may be selected by cDNA library screening; by gene-by-gene interaction mapping; or by prior knowledge of a pathway. Fluorescent and luminescent assays can be constructed using the methods provided herein. The selection of suitable PCA reporters for high-throughput or high-content (high-context) assay formats is described for a diversity of reporters, with particular detail provided for examples of monomeric enzymes and fluorescent proteins.
    Type: Application
    Filed: February 5, 2004
    Publication date: August 19, 2004
    Applicant: Odyssey Thera, Inc.
    Inventors: Stephen William Watson Michnick, Ingrid Remy, Marnie MacDonald, Jane Lamerdin, Helen Yu, John K. Westwick
  • Publication number: 20040137528
    Abstract: The present invention is directed to Protein-fragment Complementation Assays (PCAs) and assay compositions based on fluorescent proteins. The invention provides methods for fragmenting fluorescent proteins and generating mutant fragments with desired spectral characteristics for PCA. The invention encompasses assays and compositions based on fluorescent proteins from the species Aequorea, Anemonia and Anthozoa. In particular, the invention is directed to fragments of mutant fluorescent proteins having improved spectral properties over the wild-type proteins. The invention encompasses fragments of mutant versions of A. Victoria green fluorescent protein (GFP), in particular yellow fluorescent proteins (EYFP and super-EYFP), ‘Venus’, cyan, ‘citrine’, blue, cyan-green, and photoactivatable variants of GFP The invention also encompasses red fluorescent PCAs based on Discosoma red fluorescent protein (RFP PCA) and a kindling fluorescent protein PCA (KFPL PCA) derived from Anemonia sulcata.
    Type: Application
    Filed: December 1, 2003
    Publication date: July 15, 2004
    Inventors: Stephen William Watson Michnick, Marnie L. MacDonald, Jane Lamerdin
  • Publication number: 20040096381
    Abstract: Oxygen or oxygen-enriched air is employed to support combustion in furnaces (16) and (26) of part of the hydrogen sulphide content of a first feed gas stream. Sulphur vapour is extracted in condenser (32) from the resulting gas mixture so as to form a sulphur vapour depleted gas stream comprising hydrogen sulphide, sulphur dioxide, hydrogen and water vapour. The sulphur vapour depleted gas stream is passed into a catalytic reduction reactor (40) in which all the residual sulphur dioxide is reduced to hydrogen sulphide. The resulting reduced gas mixture has water vapour extracted therefrom in a quench tower (52). The resulting water vapour depleted gas stream flows to a Claus plant for further treatment typically together with a second geed gas steam comprising hydrogen sulphide. Employing both furnaces (16) and (26) makes it possible to obtain highly effective conversions to sulphur of the hydrogen sulphide on the feed gas without having the recycle any of the water vapour depleted gas.
    Type: Application
    Filed: July 3, 2003
    Publication date: May 20, 2004
    Inventors: Richard William Watson, Stephen Rhys Graville